Munich, Germany, December 20, 2010 / b3c newswire / - Since nearly 20 years the excellence in science in the Munich conurbation has led to the foundation of about 150 Biotech companies which make good progress. To bring their stories and the newest company developments to you, we recently started our own youtube-channel “Bio-M.tv”.
We invite you to the two very first issues of the Munich Biotechnology News from Bio-M.TV, where we keep you up to date on the latest research and business developments in Bavaria’s biotech sector – in English.
The first issue of our online broadcast in November was completed just in time for one of the most important events in Europe's life science industry: BIO-Europe 2010 Partnering Conference. Since the Munich Biotech Cluster m-to-the-power-of-four was given Leading-Edge Cluster status by Germany’s Federal Ministry of Education and Research early 2010, Munich provided the perfect backdrop for hosting this event.
Those 15.000 partnering meetings at the BIO-Europe Conference certainly will have an effect in the near future. Already the last few weeks, plenty of financing agreements were closed and positive company news could be published in Bavaria. Watch out our monthly overview at:
About BioM - www.bio-m.org and www.biotech-bavaria.de
BioM Biotech Cluster Development GmbH serves as the coordinating agency of the Munich Biotech Cluster and Bavarian Biotech locations (i.e. Regensburg, Würzburg, Nürnberg-Erlangen).
In Munich BioM synergizes 300 companies in the Life Sciences to one of the leading European biotech regions and top of Germany in number of companies and approved drugs.
The Munich Biotech Cluster
The leading biotechnology cluster in Germany is located in the very south of the country: in Bavaria. Bavaria is not only home of breweries since nearly 1000 years, Munich is not only the city with the famous “Oktoberfest” celebrating this old culture of historical biotechnology in the making of beer – the long lasting support of science and new technologies has taken Bavaria to the top position in Genomics, Proteomics, Metabolomics, in drug development and microscale high technology.